Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Festival Offer
This Diwali, Light up your portfolio with MoneyWorks4me Superstars starting @ ₹ 7,999 ₹ 5,999 (Offer valid till 3rd Nov 21)
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Earum Pharmaceuticals Ltd Stock Analysis

Small Cap
Evaluated by 30 users | BSE: 542724 | NSE: |
Trading

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 11.64%14.73%17.86%17.35%12.74%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 18.623.335.450.755.141
Y-o-Y Gr. Rt.-25.7%51.8%43.1%8.7%-
Adjusted EPS (Rs.) 4.736.6714.5927.071.48-0.04
Y-o-Y Gr. Rt.-41%118.7%85.5%-94.5%-
Book Value per Share (Rs.) 63.5971.0371.0396.3311.6816.68
Adjusted Net Profit 0.10.10.91.71.80
Net Op. Cash Flow (Rs. Cr.) -0.30.1-7.1-0.5-3.5-
Debt to Cash Flow from Ops -7.2124.11-1.02-19.97-2.69-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Earum Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NANA33.2%8.7%
Adjusted EPS NANA-39.5%-94.5%
Book Value per Share 00-45.2-87.9
Share Price - - - 121.5%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 7.439.927.9830.7817.9-0.28
Operating Profit Margin (%) 2.811.724.396.542.260
Net Profit Margin (%) 0.550.612.543.293.31-0.12
Debt to Equity 1.391.371.651.610.64-
Working Capital Days 0149155151182-
Cash Conversion Cycle 0718996112-
Loading price chart...
Entity Percentage Holding
Promoters 70.04%
Non-Institutions 29.96%
Pledged *0.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Data is not available for this company.

Earum Pharmaceuticals

Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and

Earum Pharmaceuticals

Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.

Business area of the company

The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.  Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback